results from a 14-week , open-label , crossover multicenter trial completed by 91 patients with chronic stable angina pectoris demonstrate that patients treated with standard nifedipine capsules may be switched to equivalent total 24-hour doses of nifedipine gits and achieve comparable or improved efficacy ( due to improved compliance ) with a more favorable side-effects profile .
C0340288
chronic stable angina
C0028066
nifedipine